Symbols / NTHI Stock $5.42 -1.63% NeOnc Technologies Holdings, Inc.

Healthcare • Biotechnology • United States • NGM
NTHI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Amir Farrokh Heshmatpour
Exch · Country NGM · United States
Market Cap 137.05M
Enterprise Value 135.28M
Income -62.15M
Sales 39.99K
FCF (ttm) 5.71M
Book/sh -0.80
Cash/sh 0.00
Employees 5
Insider 10d —
IPO Mar 26, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -10.23
PEG —
P/S 3,427.05
P/B -6.81
P/C —
EV/EBITDA —
EV/Sales 3,382.97
Quick Ratio 0.01
Current Ratio 0.07
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -3.20
EPS next Y -0.53
EPS Growth —
Revenue Growth -100.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-15
Earnings (prior) 2026-03-31
ROA -11.67%
ROE —
ROIC —
Gross Margin 100.00%
Oper. Margin -1,456.38%
Profit Margin 0.00%
Shs Outstand 25.29M
Shs Float 8.74M
Insider Own 57.66%
Instit Own 9.34%
Short Float 1.80%
Short Ratio 4.32
Short Interest 274.80K
52W High 12.99
vs 52W High -58.28%
52W Low 3.20
vs 52W Low 69.37%
Beta —
Impl. Vol. —
Rel Volume 1.12
Avg Volume 65.12K
Volume 73.20K
Target (mean) $15.00
Tgt Median $15.00
Tgt Low $15.00
Tgt High $15.00
# Analysts 1
Recom None
Prev Close $5.51
Price $5.42
Change -1.63%
About

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$15.00
Mean price target
2. Current target
$5.42
Latest analyst target
3. DCF / Fair value
$4.07
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.42
Low
$15.00
High
$15.00
Mean
$15.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-24 init BTIG — → Buy $15
News
RSS: Latest NTHI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-01 HESHMATPOUR AMIR FARROKH President — 10,000 $4.16 $41,592
2026-04-28 HESHMATPOUR AMIR FARROKH President — 10,000 $4.52 $45,180
2026-04-23 HESHMATPOUR AMIR FARROKH President — 10,000 $4.90 $49,000
2026-04-23 NEMAN-EBRAHIM YOUSHA Officer — 500 $4.88 $2,440
2026-04-10 HESHMATPOUR AMIR FARROKH President — 10,000 $4.90 $48,950
2026-04-09 HESHMATPOUR AMIR FARROKH President — 15,000 $5.19 $82,000
2026-04-09 SUH DAVID JR. Officer — 200 $5.00 $1,000
2026-04-06 HESHMATPOUR AMIR FARROKH President — 25,000 $6.09 $153,398
2026-02-27 SUH DAVID JR. Officer — 111,666 $0.00 $0
2025-11-24 HESHMATPOUR AMIR FARROKH President — 30,000 $5.98 $184,660
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.04
-51.82%
0.08
+17.79%
0.07
+252.31%
0.02
Operating Revenue
0.04
-51.82%
0.08
+17.79%
0.07
+252.31%
0.02
Operating Expense
58.21
+705.61%
7.23
-11.54%
8.17
+185.84%
2.86
Research And Development
3.64
+19.47%
3.05
+98.50%
1.53
+31.87%
1.16
Selling General And Administration
42.85
+1064.43%
3.68
+8.36%
3.40
+100.45%
1.69
General And Administrative Expense
42.85
+1064.43%
3.68
+8.36%
3.40
+100.45%
1.69
Salaries And Wages
35.56
0.00
—
—
Other Gand A
7.30
+98.34%
3.68
+8.36%
3.40
+100.45%
1.69
Other Operating Expenses
11.72
+2243.31%
0.50
-84.56%
3.24
—
Total Expenses
58.21
+705.61%
7.23
-11.54%
8.17
+185.84%
2.86
Operating Income
-58.17
-714.41%
-7.14
+11.80%
-8.10
-185.37%
-2.84
Total Operating Income As Reported
-58.24
-715.40%
-7.14
+41.44%
-12.20
-329.86%
-2.84
EBITDA
-59.61
-555.33%
-9.10
+25.43%
-12.20
-328.50%
-2.85
Normalized EBITDA
-58.92
-738.59%
-7.03
+13.24%
-8.10
-184.47%
-2.85
Reconciled Depreciation
0.04
-85.18%
0.25
0.00
—
EBIT
-59.64
-538.47%
-9.34
+23.42%
-12.20
-328.50%
-2.85
Total Unusual Items
-0.69
+66.69%
-2.07
+49.51%
-4.10
0.00
Total Unusual Items Excluding Goodwill
-0.69
+66.69%
-2.07
+49.51%
-4.10
0.00
Special Income Charges
0.00
+100.00%
-2.07
+49.51%
-4.10
0.00
Other Special Charges
—
2.07
-49.51%
4.10
—
Net Income
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Pretax Income
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Net Non Operating Interest Income Expense
-3.29
-22.39%
-2.69
+1.37%
-2.72
-1260.66%
-0.20
Interest Expense Non Operating
2.50
-2.05%
2.56
-6.11%
2.72
+1260.66%
0.20
Net Interest Income
-3.29
-22.39%
-2.69
+1.37%
-2.72
-1260.66%
-0.20
Interest Expense
2.50
-2.05%
2.56
-6.11%
2.72
+1260.66%
0.20
Interest Income Non Operating
0.33
+1930.51%
0.02
0.00
—
Interest Income
0.33
+1930.51%
0.02
0.00
—
Other Income Expense
-0.69
+66.69%
-2.07
+49.51%
-4.10
-45455.56%
-0.01
Other Non Operating Income Expenses
—
—
—
-0.01
Gain On Sale Of Security
-0.69
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Net Income From Continuing Operation Net Minority Interest
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Net Income From Continuing And Discontinued Operation
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Net Income Continuous Operations
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Normalized Income
-61.46
-525.29%
-9.83
+9.17%
-10.82
-255.17%
-3.05
Net Income Common Stockholders
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Diluted EPS
—
-0.63
+20.26%
-0.80
-389.73%
-0.16
Basic EPS
—
-0.63
+20.26%
-0.80
-389.73%
-0.16
Basic Average Shares
—
18.75
+0.00%
18.75
+0.00%
18.75
Diluted Average Shares
—
18.75
+0.00%
18.75
+0.00%
18.75
Diluted NI Availto Com Stockholders
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Total Other Finance Cost
1.11
+665.34%
0.15
—
—
Line Item Trend 2025-12-31
Total Assets
2.82
Current Assets
1.39
Cash Cash Equivalents And Short Term Investments
0.06
Cash And Cash Equivalents
0.06
Cash Financial
0.06
Prepaid Assets
0.58
Current Deferred Assets
0.08
Hedging Assets Current
0.67
Total Non Current Assets
1.43
Net PPE
0.36
Gross PPE
0.36
Other Properties
0.36
Goodwill And Other Intangible Assets
0.50
Other Non Current Assets
0.05
Total Liabilities Net Minority Interest
20.33
Current Liabilities
20.04
Payables And Accrued Expenses
13.76
Payables
12.01
Accounts Payable
7.11
Other Payable
4.89
Current Accrued Expenses
1.76
Pensionand Other Post Retirement Benefit Plans Current
0.26
Current Debt And Capital Lease Obligation
6.02
Current Debt
5.95
Other Current Borrowings
5.95
Current Capital Lease Obligation
0.07
Current Deferred Liabilities
—
Current Deferred Revenue
—
Total Non Current Liabilities Net Minority Interest
0.29
Long Term Debt And Capital Lease Obligation
0.29
Long Term Capital Lease Obligation
0.29
Stockholders Equity
-17.51
Common Stock Equity
-17.51
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
21.99
Ordinary Shares Number
21.69
Treasury Shares Number
0.30
Additional Paid In Capital
97.95
Retained Earnings
-112.75
Treasury Stock
2.71
Total Equity Gross Minority Interest
-17.51
Total Capitalization
-17.51
Working Capital
-18.65
Invested Capital
-11.56
Total Debt
6.31
Net Debt
5.89
Capital Lease Obligations
0.36
Net Tangible Assets
-18.01
Tangible Book Value
-18.01
Current Notes Payable
—
Dueto Related Parties Current
—
Financial Assets
0.53
Preferred Stock Equity
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-20.36
-383.25%
-4.21
-124.14%
-1.88
-113.22%
-0.88
Cash Flow From Continuing Operating Activities
-20.36
-383.25%
-4.21
-124.14%
-1.88
-113.22%
-0.88
Net Income From Continuing Operations
-62.15
-422.30%
-11.90
+20.26%
-14.92
-389.74%
-3.05
Depreciation Amortization Depletion
0.04
-85.18%
0.25
0.00
—
Depreciation
0.04
-85.18%
0.25
0.00
—
Depreciation And Amortization
0.04
-85.18%
0.25
0.00
—
Other Non Cash Items
3.36
+5.79%
3.18
-71.94%
11.33
+5375.01%
0.21
Stock Based Compensation
35.56
0.00
0.00
-100.00%
1.29
Asset Impairment Charge
0.00
-100.00%
0.70
0.00
—
Operating Gains Losses
0.69
-66.69%
2.07
—
—
Gain Loss On Investment Securities
0.69
—
—
—
Change In Working Capital
2.14
+43.89%
1.49
-13.27%
1.71
+157.24%
0.67
Change In Receivables
—
—
—
0.00
Changes In Account Receivables
—
—
—
0.00
Change In Prepaid Assets
-0.20
-58.97%
-0.12
-399.02%
-0.02
+71.82%
-0.09
Change In Payables And Accrued Expense
2.39
+29.10%
1.85
+6.68%
1.74
+130.53%
0.75
Change In Accrued Expense
1.28
+2175.69%
0.06
-91.73%
0.68
+1457.49%
-0.05
Change In Payable
1.12
-37.89%
1.80
+69.71%
1.06
+31.79%
0.80
Change In Account Payable
1.12
-37.89%
1.80
+69.71%
1.06
+31.79%
0.80
Change In Other Working Capital
—
—
—
-0.05
Change In Other Current Assets
-0.05
0.00
—
—
Change In Other Current Liabilities
-0.01
+95.03%
-0.24
0.00
—
Investing Cash Flow
-0.50
0.00
—
—
Cash Flow From Continuing Investing Activities
-0.50
0.00
—
—
Capital Expenditure
-0.50
—
—
—
Net Intangibles Purchase And Sale
-0.50
0.00
—
—
Purchase Of Intangibles
-0.50
0.00
—
—
Financing Cash Flow
20.86
+391.12%
4.25
+232.16%
1.28
-14.19%
1.49
Cash Flow From Continuing Financing Activities
20.86
+391.12%
4.25
+232.16%
1.28
-14.19%
1.49
Net Issuance Payments Of Debt
3.70
+3565.14%
0.10
-92.65%
1.37
+753.66%
-0.21
Issuance Of Debt
4.30
+382.05%
0.89
-74.57%
3.51
+2706.38%
0.12
Repayment Of Debt
-0.60
+24.15%
-0.79
+62.95%
-2.14
-537.40%
-0.34
Long Term Debt Issuance
4.00
0.00
—
—
Net Long Term Debt Issuance
4.00
0.00
—
—
Short Term Debt Issuance
0.30
-66.37%
0.89
-74.57%
3.51
+2706.38%
0.12
Short Term Debt Payments
-0.60
+24.15%
-0.79
+62.95%
-2.14
-537.40%
-0.34
Net Short Term Debt Issuance
-0.30
-397.17%
0.10
-92.65%
1.37
+753.66%
-0.21
Net Common Stock Issuance
17.16
+271.72%
4.62
+1025630.89%
0.00
-99.98%
2.40
Net Other Financing Charges
—
-0.47
-396.77%
-0.09
+86.49%
-0.70
Changes In Cash
-0.01
-118.66%
0.03
+105.49%
-0.60
-198.88%
0.61
Beginning Cash Position
0.06
+103.67%
0.03
-94.97%
0.63
+2429.75%
0.03
End Cash Position
0.06
-9.50%
0.06
+103.67%
0.03
-94.97%
0.63
Free Cash Flow
-20.86
-395.12%
-4.21
-124.14%
-1.88
-113.22%
-0.88
Interest Paid Supplemental Data
—
—
0.00
-100.00%
0.00
Common Stock Issuance
17.16
+271.72%
4.62
+1025630.89%
0.00
-99.98%
2.40
Issuance Of Capital Stock
17.16
+271.72%
4.62
+1025630.89%
0.00
-99.98%
2.40
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category